David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$880M |
| 3 |
Boeing
BA
|
+$850M |
| 4 |
Eli Lilly
LLY
|
+$689M |
| 5 |
Tesla
TSLA
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$964M |
| 2 |
Apple
AAPL
|
+$606M |
| 3 |
Workday
WDAY
|
+$520M |
| 4 |
Palantir
PLTR
|
+$514M |
| 5 |
Spotify
SPOT
|
+$431M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.54% |
| 2 | Consumer Discretionary | 8.87% |
| 3 | Healthcare | 8.21% |
| 4 | Financials | 5.68% |
| 5 | Industrials | 4.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Applied Digital
APLD
$8.08B
| $8M | 0.01% |
+1,046,595
| New | +$8.7M |
|
1527
Global E Online
GLBE
$6.71B
| $7.99M | 0.01% |
+146,468
| New | +$6.63M |
|
1528
Aptiv
APTV
$9.63B
| $7.93M | 0.01% |
131,140
-180,922
| -58% | -$11.1M |
|
1529
CALL
Gilead Sciences
GILD
$183B
| $7.93M | 0.01% |
85,800
-34,800
| -29% | -$3.13M |
|
|
HPP
1530
Hudson Pacific Properties
HPP
$800M
| $7.89M | 0.01% |
372,217
+182,177
| +96% | +$4.98M |
|
1531
CALL
Bunge Global
BG
$21.3B
| $7.89M | 0.01% |
101,500
+29,300
| +41% | +$2.57M |
|
1532
Gartner
IT
$12.6B
| $7.87M | 0.01% |
16,254
-43,584
| -73% | -$22.5M |
|
|
AVNS
1533
DELISTED
Avanos Medical
AVNS
| $7.87M | 0.01% |
494,627
+148,902
| +43% | +$2.95M |
|
1534
Theravance Biopharma
TBPH
$883M
| $7.85M | 0.01% |
833,943
+69,178
| +9% | +$629K |
|
1535
Vanguard Health Care ETF
VHT
$19.8B
| $7.84M | 0.01% |
30,917
+26,402
| +585% | +$7.11M |
|
|
EHAB
1536
DELISTED
Enhabit
EHAB
| $7.84M | 0.01% |
1,004,215
+250,215
| +33% | +$1.9M |
|
1537
PUT
Magna International
MGA
$17.9B
| $7.84M | 0.01% |
187,600
+56,600
| +43% | +$2.43M |
|
1538
Harley-Davidson
HOG
$2.89B
| $7.81M | 0.01% |
259,373
-35,866
| -12% | -$1.19M |
|
|
ACCD
1539
DELISTED
Accolade Inc
ACCD
| $7.8M | 0.01% |
2,280,783
+998,423
| +78% | +$3.55M |
|
1540
Solventum
SOLV
$15.5B
| $7.79M | 0.01% |
117,985
+75,171
| +176% | +$5.26M |
|
1541
Xperi
XPER
$305M
| $7.79M | 0.01% |
758,210
+125,021
| +20% | +$1.17M |
|
1542
JELD-WEN Holding
JELD
$210M
| $7.78M | 0.01% |
950,217
+426,085
| +81% | +$5.13M |
|
1543
Gentherm
THRM
$1.22B
| $7.77M | 0.01% |
194,584
+81,780
| +72% | +$3.43M |
|
1544
CALL
Applied Optoelectronics
AAOI
$9.54B
| $7.77M | 0.01% |
+210,700
| New | +$5.67M |
|
1545
US Physical Therapy
USPH
$1.16B
| $7.73M | 0.01% |
87,184
+27,028
| +45% | +$2.41M |
|
|
GATO
1546
DELISTED
Gatos Silver, Inc.
GATO
| $7.72M | 0.01% |
552,479
+257,497
| +87% | +$4.19M |
|
1547
Hyliion Holdings
HYLN
$584M
| $7.7M | 0.01% |
2,949,691
-511,755
| -15% | -$1.42M |
|
1548
SITE Centers
SITC
$160M
| $7.68M | 0.01% |
502,422
-190,318
| -27% | -$3.07M |
|
1549
E.W. Scripps
SSP
$305M
| $7.65M | 0.01% |
3,459,777
-34,172
| -1% | -$78.9K |
|
1550
CALL
XPeng
XPEV
$11B
| $7.63M | 0.01% |
645,200
+555,500
| +619% | +$6.87M |
|
Similar funds
David Shaw's Q4 2024 Portfolio in Review
As of Q4 2024, David Shaw held 5,079 positions worth $136B, up 17% from $116B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw deployed $10.6B of net new capital in Q4 2024, opening 591 new positions and adding to 1,620 existing holdings. Its largest new stake was Lam Research: 3,525,438 shares worth $255M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was NVIDIA, an estimated $964M trimmed.
- David Shaw's largest Q4 2024 buy was Lam Research: 3,525,438 shares worth $255M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $3.7B increase.
- David Shaw's biggest Q4 2024 reduction was NVIDIA, cutting an estimated $964M.
- David Shaw fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $81.4M.
- David Shaw's ten largest holdings make up 11% of its $136B portfolio in Q4 2024.
- David Shaw opened 591 new positions and closed 731 in Q4 2024.
- David Shaw's portfolio value rose 17% quarter-over-quarter to $136B.
Based on D.E. Shaw & Co's 13F filing for Q4 2024, filed 14 Feb 2025.